The role of measles elimination in development of a National Immunization Program

Pediatric Infectious Disease Journal

Volumn 25, Issue 12, 2006, Pages 1093-1101

  Orenstein, Walter A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Elimination; History; Immunization; Measles

Indexed keywords

ARTICLE; HEALTH PROGRAM; HUMAN; MEASLES; POLIOMYELITIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RUBELLA; UNITED STATES; URBAN AREA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MEASLES; UNITED STATES;

EID: 33845404108     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000246840.13477.28     Document Type: Article

References (42)

1. Centers for Disease Control and Prevention. Achievements in public health, 1900-1999 impact of vaccines universally recommended for children - United States, 1990-1998. MMWR Morb Mortal Wkly Rep. 1999;48:243-248.
2. Zhou F, Santoli J, Messonnier ML, et al. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001. Arch Pediatr Adolesc Med. 2005;159:1136-1144.
3. Orenstein WA, Rodewald LE, Hinman AR. Immunization in the United States. In: Plotkin S, Orenstein WA, eds. Vaccines, 4th ed. Philadelphia: Elsevier; 2004:1357-1386.
4. Hinman AR, Orenstein WA, Rodewald L. Financing immunizations in the United States. Clin Infect Dis. 2004;38:1440-1446.
5. Langmuir AD. Medical importance of measles. Am J Dis Child. 1962;103:224-226.
6. Strebel PJ, Papania MJ, Halsey NA. Measles vaccine. In: Plotkin S, Orenstein WA, eds. Vaccines. Philadelphia: Elsevier; 2004:389-440.
7. Sencer DJ, Dull HB, Langmuir AD. Epidemiologic basis for eradication of measles in 1967. Public Health Rep. 1967;82:253-256.
8. Hinman AR, Brandling-Bennet AD, Bernier RH, Kirby CD, Eddins DL. Current features of measles in the United States: Feasibility of measles elimination. Epidemiol Rev. 1980;2:153-170.
9. Conrad JL, Wallace R, Witte JJ. The epidemiologic rationale for the failure to eradicate measles in the United States. Am J Public Health. 1971;61:2304-2310.
10. Fenner F HD, Arita I, Jezek Z, Ladnyi LD. Smallpox and Its Eradication. Geneva: World Health Organization; 1988.
11. Foege WH, Millar JD, Lane JM. Selective epidemiologic control in smallpox eradication. Am J Epidemiol. 1971;94:311-315.
12. PEM F. Community immunity. In: Plotkin S, Orenstein WA, eds. Vaccines. Philadelphia: Elsevier; 2004:1443-1461.
13. Landrigan PJ. Epidemic measles in a divided city. JAMA. 1972;221:567-570.
14. Orenstein WA, Hinman AR. The immunization system in the United States - The role of school immunization laws. Vaccine. 1999;17(suppl 3):S19-24.
15. Centers for Disease Control and Prevention. Measles and school immunization requirements - United States. MMWR Morb Mortal Wkly Rep. 1978;27:303-304.
16. Hinman AR, Brandling-Bennett AD, Nieburg PI. The opportunity and obligation to eliminate measles from the United States. JAMA. 1979;242:1157-1162.
17. Hinman AR. The new US initiative in childhood immunization. Bull Pan Am Health Organ. 1979;13:169-176.
18. Hinman AR, Orenstein WA, Papania MJ. Evolution of measles elimination strategies in the United States. J Infect Dis. 2004;189(suppl 1):S17-22.
19. Public health considerations of infectious diseases in child day care centers. The Child Day Care Infectious Disease Study Group. J Pediatr. 1984;105:683-701.
20. Crawford GE, Gremillion DH. Epidemic measles and rubella in air force recruits: Impact of immunization. J Infect Dis. 1981;144:403-410.
21. Measles - US military. MMWR Morb Mortal Wkly Rep. 1981;30:314-316.
22. Markowitz LE, Preblud SR, Orenstein WA, et al. Patterns of transmission in measles outbreaks in the United States, 1985-1986. N Engl J Med. 1989;320:75-81.
23. Simpson DM, Ezzati-Rice TM, Zell ER. Forty years and four surveys: How does our measuring measure up? Am J Prev Med. 2001;20:6-14.
24. Hersh BS, Markowitz LE, Maes EF, et al. The geographic distribution of measles in the United States, 1980 through 1989. JAMA. 1992;267:1936-1941.
25. Public-sector vaccination efforts in response to the resurgence of measles among preschool-aged children - United States, 1989-1991. MMWR Morb Mortal Wkly Rep. 1992;41:522-525.
26. Atkinson WL, Orenstein WA, Krugman S. The resurgence of measles in the United States, 1989-1990. Annu Rev Med. 1992;43:451-463.
27. Atkinson WL, Hadler SC, Redd SB, Orenstein WA. Measles surveillance - United States, 1991. MMWR CDC Surveill Summ. 1992;41:1-12.
28. Markowitz LE, Preblud SR, Fine PE, Orenstein WA. Duration of live measles vaccine-induced immunity. Pediatr Infect Dis J. 1990;9:101-110.
29. Measles prevention. MMWR Morb Mortal Wkly Rep. 1989;38(suppl 9):1-18.
30. American Academy of Pediatrics Committee on Infectious Diseases. Measles: Reassessment of the current immunization policy. Pediatrics. 1989;84:1110-1113.
31. The measles epidemic. The problems, barriers, and recommendations. The National Vaccine Advisory Committee. JAMA. 1991;266:1547-1552.
32. Grabowsky M, Orenstein WA, Marcuse EK. The critical role of provider practices in undervaccination. Pediatrics. 1996;97:735-737.
33. Orenstein WA, Atkinson W, Mason D, Bernier RH. Barriers to vaccinating preschool children. J Health Care Poor Underserved. 1990;1:315-330.
34. Woods DR, Mason DD. Six areas lead national early immunization drive. Public Health Rep. 1992;107:252-256.
35. From the Centers for Disease Control and Prevention. Reported vaccine-preventable diseases - United States, 1993, and the childhood immunization initiative. JAMA. 1994;271:651-652.
36. National, state, and urban area vaccination coverage among children aged 19-35 months - United States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:988-993.
37. Papania MJ, Seward JF, Redd SB, et al. Epidemiology of measles in the United States, 1997-2001. J Infect Dis. 2004;189(suppl 1):S61-68.
38. Katz SL, Hinman AR. Summary and conclusions: Measles elimination meeting, 16-17 March 2000. J Infect Dis. 2004;189(suppl 1):S43-47.
39. Orenstein WA, Papania MJ, Wharton ME. Measles elimination in the United States. J Infect Dis. 2004;189(suppl 1):S1-3.
40. Hinman AR, Orenstein WA, Santoli JM, Rodewald LE, Cochi SL. Vaccine shortages: History, impact, and prospects for the future. Annu Rev Public Health. 2006;27:235-259.
41. Rodewald LE, Orenstein WA, Mason DD, Cochi SL. Vaccine supply problems: A perspective of the Centers for Disease Control and Prevention. Clin Infect Dis. 2006;42(suppl 3):S104-110.
42. Orenstein WA, Douglas RG, Rodewald LE, Hinman AR. Immunizations in the United States: Success, structure, and stress. Health Aff (Millwood). 2005;24:599-610.